§ 01 — Bioinformatics & NGS Analysis

Rua

رُؤَىٰ

NGS analysis for labs and biotech that need answers, not just pipelines.

Rua delivers rigorous bioinformatics from raw reads to biological insight — RNA-seq, ChIP-seq, CUT&RUN, and beyond.

§ 02

What we offer

RNA-seq Differential Expression & Pathway Analysis

End-to-end transcriptomic profiling — from quality control and alignment to differential expression and pathway enrichment. Rua delivers publication-ready figures, annotated gene lists, and interpretive summaries your team can act on.

ChIP-seq Peak Calling & Differential Binding

Robust histone-mark and transcription-factor ChIP-seq workflows. We identify enriched regions, annotate peaks to genomic features, and quantify differential occupancy across conditions with full statistical documentation.

CUT&RUN High-Resolution Chromatin Profiling

Specialized CUT&RUN / CUT&TAG processing optimized for low-input and low-background signal. Rua applies spike-in normalization, fragment-size QC, and fine-resolution peak calling tailored to your factor of interest.

Other NGS Analyses on Request

Custom pipelines for any sequencing assay. Whether the protocol is standard or the experimental design unusual, Rua will build or adapt a reproducible workflow matched to your scientific question.

§ 03

Examples

Representative analyses for illustration. Actual client work is confidential.

RNA-seqDESeq2Volcano Plot

Drug-Response Transcriptomic Profiling

Loading plot…

Problem

Characterize the transcriptional response to dexamethasone in a cell line model.

Approach

Standard bulk RNA-seq pipeline with DESeq2 for differential expression, pathway enrichment, and visualization.

Outcome

900+ differentially expressed genes identified, including the canonical glucocorticoid-responsive signature (FKBP5, TSC22D3, DUSP1), delivered as publication-ready figures and a written report.

ChIP-seqMACS2DiffBind

Chromatin Factor Binding Across Treatment Conditions

Loading plot…

Problem

Profile binding of a chromatin factor across treatment conditions.

Approach

Alignment, peak calling, and differential binding analysis with full quality controls.

Outcome

1,000+ high-confidence peaks characterized, with ranked binding profiles and differential regions identified between conditions.

CUT&RUNSEACRMetagene

Histone Modification Profiling at TSSs by CUT&RUN

Loading plot…

Problem

Compare histone modification profiles at TSSs across three conditions with limited input material.

Approach

CUT&RUN pipeline with spike-in normalization and metagene profiling at transcription start sites.

Outcome

Clear differential TSS occupancy between treatments with tight confidence intervals from replicates — Treatment A showed enrichment, Treatment B showed reduction relative to control.

§ 04

About Rua

رؤى — 'insights' in Arabic. The clarity we bring to your sequencing data.

Rua is a bioinformatics services company specializing in next-generation sequencing data analysis, with deep expertise in epigenomics and transcriptomics. We work with academic research groups and biotech teams who need expert-level analytical capacity — without the overhead of a full-time hire. Our focus is on the assays that matter most in modern chromatin and gene-expression biology: RNA-seq, ChIP-seq, CUT&RUN, and the custom pipelines that tie them together.

Every engagement at Rua begins with understanding your scientific question, not just your file formats. We deliver reproducible, version-controlled workflows, publication-ready figures, and written summaries that communicate results clearly to bench scientists and grant reviewers alike. Clients can expect rigorous statistical methodology, transparent documentation, and a single point of contact from raw data to final report.

§ 05

Let's talk about your data.

Send a brief description of your experiment, data type, and timeline. Rua responds within one business day.

hello@rua.bio

Supporting research teams at

University of Pennsylvania
Children's Hospital of Philadelphia
University of Michigan
University of Southern Denmark
MD Anderson Cancer Center

Institution logos are the property of their respective owners and do not imply endorsement.